Key Highlights

  • XRF Scientific shares were priced at $1.76, down 9.54% over one year.
  • First-half revenue increased 9.1% to $31.3 million.
  • First-half EBIT rose 7.1% to $7.4 million.
  • March-quarter revenue grew 13.8%, supported by international demand.

XRF Scientific shares were priced at $1.76 after a one-year move of -9.54%. The latest company update provides context for a market capitalisation of approximately $251.04 million.

Company Overview

XRF Scientific makes equipment and consumables used to prepare and analyse samples for mining, construction and laboratory customers. Commodity activity, equipment orders, recurring consumables and overseas expansion affect earnings.

Latest Update

First-half FY26 revenue increased 9.1% to $31.3 million and EBIT rose 7.1% to $7.4 million. March-quarter revenue then grew 13.8% to $15.8 million, helped by international sales, particularly in Asia. The company has opened an Indian office and acquired a combustion gas analysis business to broaden its offering.

Financial and Share-Price Snapshot

At $1.76, XRF Scientific had a market capitalisation of about $251.04 million following a 9.54% one-year decline. Operating growth has continued, but the lower share price indicates that expectations for future growth and valuation have moderated.

What May Be Watched Next

Readers may watch Asian sales, capital-equipment orders, gold-sector demand, recurring consumables, acquisition integration and profit margins.

Key Risks

Risks include mining-cycle weakness, lumpy equipment orders, currency movements, acquisition integration, supply disruption and competition.